List all clinical trials by discovery date. Accepts regular expressions in search.

GET /trials/?page=70
HTTP 200 OK
Allow: GET, POST, HEAD, OPTIONS
Content-Type: application/json
Vary: Accept

{
    "count": 728,
    "next": "http://api.gregory-ms.com/trials/?page=71",
    "previous": "http://api.gregory-ms.com/trials/?page=69",
    "results": [
        {
            "trial_id": 42,
            "title": "Humoral and T-Cell Responses to COVID-19 Vaccination in Multiple Sclerosis Patients Treated With Ocrelizumab Treated With Ocrelizumab or Natalizumab",
            "summary": "<b>Conditions</b>:    Multiple Sclerosis;   Demyelinating Autoimmune Diseases, CNS;   Autoimmune Diseases of the Nervous System;   Nervous System Diseases;   Demyelinating Diseases;   Autoimmune Diseases;   Immune System Diseases;   Pathologic Processes<br/><b>Intervention</b>:    Device: Elecsys semi-quantitative Anti-SARS-CoV-2 antibody test<br/><b>Sponsor</b>:    Dragonfly Research, LLC<br/><b>Recruiting</b>",
            "published_date": "2021-04-08T16:00:00Z",
            "discovery_date": "2021-04-08T11:57:29Z",
            "link": "https://clinicaltrials.gov/ct2/show/NCT04837651?cond=Multiple+Sclerosis&sfpd_d=14&sel_rss=new14",
            "source": "Clinical Trials.gov",
            "relevant": null
        },
        {
            "trial_id": 37,
            "title": "The Effects of Relaxation Techniques on Pain, Fatigue and Kinesiophobia in Multiple Sclerosis Patients: A Three Arms Randomized Trial",
            "summary": "<b>Conditions</b>:    Multiple Sclerosis, Relapsing-Remitting;   Pain, Chronic;   Fatigue Syndrome, Chronic;   Kinesiophobia<br/><b>Interventions</b>:    Behavioral: PMR: Progressive Muscle Relaxation;   Behavioral: BRT:Benson Relaxation Technique<br/><b>Sponsor</b>:    Hacettepe University<br/><b>Completed</b>",
            "published_date": "2021-04-06T16:00:00Z",
            "discovery_date": "2021-04-06T11:14:24Z",
            "link": "https://clinicaltrials.gov/ct2/show/NCT04833673?cond=Multiple+Sclerosis&sfpd_d=14&sel_rss=new14",
            "source": "Clinical Trials.gov",
            "relevant": null
        },
        {
            "trial_id": 36,
            "title": "Study of Tysabri in Early Relapsing Remitting Multiple Sclerosis Participants",
            "summary": "<b>Condition</b>:    Relapsing Remitting Multiple Sclerosis<br/><b>Intervention</b>:    Drug: Natalizumab<br/><b>Sponsor</b>:    Biogen<br/><b>Recruiting</b>",
            "published_date": "2021-04-05T16:00:00Z",
            "discovery_date": "2021-04-05T11:38:24Z",
            "link": "https://clinicaltrials.gov/ct2/show/NCT04832399?cond=Multiple+Sclerosis&sfpd_d=14&sel_rss=new14",
            "source": "Clinical Trials.gov",
            "relevant": null
        },
        {
            "trial_id": 35,
            "title": "Effects of a Multiple Sclerosis Relapse Therapy on Offspring Neurocognitive Development and Behaviour",
            "summary": "<b>Condition</b>:    Multiple Sclerosis<br/><b>Intervention</b>:    Other: Exposure to methylprednisolone during pregnancy<br/><b>Sponsors</b>:    Jena University Hospital;   Ruhr University of Bochum;   Interdisciplinary Center of Clinical Research of the Medical Faculty Jena;   Merck Healthcare KGaA, Darmstadt, Germany, an affiliate of Merck KGaA, Darmstadt, Germany<br/><b>Recruiting</b>",
            "published_date": "2021-04-05T16:00:00Z",
            "discovery_date": "2021-04-05T11:38:24Z",
            "link": "https://clinicaltrials.gov/ct2/show/NCT04832269?cond=Multiple+Sclerosis&sfpd_d=14&sel_rss=new14",
            "source": "Clinical Trials.gov",
            "relevant": null
        },
        {
            "trial_id": 34,
            "title": "Imaging Evaluation of Central Nervous Autoimmune Diseases",
            "summary": "<b>Conditions</b>:    MS (Multiple Sclerosis);   NMO Spectrum Disorder<br/><b>Intervention</b>:    Diagnostic Test: MRI<br/><b>Sponsor</b>:    Qilu Hospital of Shandong University<br/><b>Not yet recruiting</b>",
            "published_date": "2021-03-30T16:00:00Z",
            "discovery_date": "2021-03-30T11:05:24Z",
            "link": "https://clinicaltrials.gov/ct2/show/NCT04822623?cond=Multiple+Sclerosis&sfpd_d=14&sel_rss=new14",
            "source": "Clinical Trials.gov",
            "relevant": null
        },
        {
            "trial_id": 33,
            "title": "Effects of Repeated Mesenchymal Stem Cells (MSC) in Patients With Progressive Multiple Sclerosis",
            "summary": "<b>Condition</b>:    Multiple Sclerosis<br/><b>Intervention</b>:    Biological: Mesenchymal Stem Cells (MSC)<br/><b>Sponsor</b>:    Hadassah Medical Organization<br/><b>Completed</b>",
            "published_date": "2021-03-30T16:00:00Z",
            "discovery_date": "2021-03-30T11:05:24Z",
            "link": "https://clinicaltrials.gov/ct2/show/NCT04823000?cond=Multiple+Sclerosis&sfpd_d=14&sel_rss=new14",
            "source": "Clinical Trials.gov",
            "relevant": null
        },
        {
            "trial_id": 32,
            "title": "Spinal Cord Lesion Detection in Multiple Sclerosis Using Novel MRI Sequences",
            "summary": "<b>Condition</b>:    Multiple Sclerosis (MS)<br/><b>Interventions</b>:    Procedure: SC MRI;   Other: patient questionnaire<br/><b>Sponsors</b>:    University Hospital, Basel, Switzerland;   Freie Akademische Gesellschaft Basel<br/><b>Not yet recruiting</b>",
            "published_date": "2021-03-29T16:00:00Z",
            "discovery_date": "2021-03-29T11:19:37Z",
            "link": "https://clinicaltrials.gov/ct2/show/NCT04819737?cond=Multiple+Sclerosis&sfpd_d=14&sel_rss=new14",
            "source": "Clinical Trials.gov",
            "relevant": null
        },
        {
            "trial_id": 31,
            "title": "Study of the Mechanisms of Action of Cladribine in Multiple Sclerosis",
            "summary": "<b>Condition</b>:    Multiple Sclerosis<br/><b>Intervention</b>:    Other: biological collection<br/><b>Sponsor</b>:    University Hospital, Rouen<br/><b>Recruiting</b>",
            "published_date": "2021-03-29T16:00:00Z",
            "discovery_date": "2021-03-29T11:19:36Z",
            "link": "https://clinicaltrials.gov/ct2/show/NCT04821596?cond=Multiple+Sclerosis&sfpd_d=14&sel_rss=new14",
            "source": "Clinical Trials.gov",
            "relevant": null
        },
        {
            "trial_id": 30,
            "title": "Botulinum Toxin A vs Anticholinergic Treatment of Neurogenic Overactive Bladder in Patients With Multiple Sclerosis",
            "summary": "<b>Conditions</b>:    Urinary Bladder, Neurogenic;   Multiple Sclerosis<br/><b>Interventions</b>:    Drug: VESIcare 10Mg Tablet;   Drug: Botox 100 UNT Injection<br/><b>Sponsors</b>:    Brigitte Schürch;   Centre Hospitalier Universitaire Vaudois<br/><b>Not yet recruiting</b>",
            "published_date": "2021-03-26T16:00:00Z",
            "discovery_date": "2021-03-26T13:30:35Z",
            "link": "https://clinicaltrials.gov/ct2/show/NCT04819360?cond=Multiple+Sclerosis&sfpd_d=14&sel_rss=new14",
            "source": "Clinical Trials.gov",
            "relevant": null
        },
        {
            "trial_id": 29,
            "title": "The Use of Arabic Otago Exercise Program in People With Multiple Sclerosis",
            "summary": "<b>Condition</b>:    Multiple Sclerosis<br/><b>Intervention</b>:    Other: Otago Exercise Program<br/><b>Sponsor</b>:    University of Jordan<br/><b>Not yet recruiting</b>",
            "published_date": "2021-03-26T16:00:00Z",
            "discovery_date": "2021-03-26T13:30:35Z",
            "link": "https://clinicaltrials.gov/ct2/show/NCT04818008?cond=Multiple+Sclerosis&sfpd_d=14&sel_rss=new14",
            "source": "Clinical Trials.gov",
            "relevant": null
        }
    ]
}